Clearance of Tissue Plasminogen Activator (TPA) and TPA/Plasminogen Activator Inhibitor Type 1 (PAI-1) Complex: Relationship to Elevated TPA Antigen in Patients With High PAI-1 Activity Levels

Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris

Thompson, S. G., Kienast, J., Pyke, S., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,819

PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION

Hamsten, A., Walldius, G., Szamosi, A., Blombäck, M., de Faire, U., Dahlén, G. H., Landou, C., & Wiman, B. (1987) · The Lancet · doi:10.1016/s0140-6736(87)93050-9 · Cited by 1,474

Blood Transfusion in Clinical Medicine.

(1952) · JAMA · doi:10.1001/jama.1952.03680120098032 · Cited by 1,290

Enhanced expression of PAI–1 in visceral fat: Possible contributor to vascular disease in obeisty

Shimomura, I., Funahasm, T., Takahashi, M., Maeda, K., Kotani, K., Nakamura, T., Yamashita, S., Miura, M., Fukuda, Y., Takemura, K., et al. (1996) · Nature Medicine · doi:10.1038/nm0796-800 · Cited by 889

Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study

MEADE, T. (1993) · The Lancet · doi:10.1016/0140-6736(93)92062-x · Cited by 711

Production of Plasminogen Activator Inhibitor 1 by Human Adipose Tissue: Possible Link Between Visceral Fat Accumulation and Vascular Disease

Alessi, M., Peiretti, F., Morange, P., Henry, M., Nalbone, G., & Juhan-Vague, I. (1997) · Diabetes · doi:10.2337/diab.46.5.860 · Cited by 614

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

Ridker, P. M., Vaughan, D. E., Manson, J., Hennekens, C. H., & Stampfer, M. (1993) · The Lancet · doi:10.1016/0140-6736(93)90998-v · Cited by 580

Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma

Kruithof, E. K. O., Trân-Thang, C., Ransijn, A., & Bachmann, F. (1984) · Blood · doi:10.1182/blood.v64.4.907.bloodjournal644907 · Cited by 400

An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation.

Cesarman, G., Guevara, C. A., & Hajjar, K. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31948-8 · Cited by 342

Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide.

Samad, F., Yamamoto, K., & Loskutoff, D. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118404 · Cited by 301

Fibrinolysis status in the Budd–Chiari syndrome in China

Zhang, K., Xu, H., Wei, N., Maoheng, Z., & Fu, Y. (2014) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000143 · Cited by 2

Système du plasminogène et son exploration

Lebrazi, J., Samama, M., & Bachmann, F. (2003) · Encyclopédie médico-chirurgicale. Hématologie · doi:10.1016/s1155-1984(03)00048-7 · Cited by 2

Endothelin-1 does not contribute to the release of tissue plasminogen activator in vivo in man

Newby, D. E., Strachan, F. E., Johnston, N. R., & Webb, D. J. (1999) · Fibrinolysis and Proteolysis · doi:10.1016/s0268-9499(99)90070-x · Cited by 2

Genetic aspects of stroke : association and linkage studies in a northern Swedish population

Wiklund, P.-G. (2005) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 2

Regionally differentiated fibrinolytic responses during volume‐resuscitated acute endotoxemia in pigs

Nyberg, A., Seeman-Lodding, H., Ahlqvist, M. M., Fagerberg, A., Jern, C., & Åneman, A. (2003) · Acta Anaesthesiologica Scandinavica · doi:10.1034/j.1399-6576.2003.00219.x · Cited by 2

Mechanisms and effects of low plasminogen activator inhibitor type 1 activity

Ågren, A. (2008) · Figshare · Cited by 2

Removing plasmin from the equation – Something to chew on…

Morrow, G. B., & Mutch, N. J. (2021) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15590 · Cited by 1

Pharmacokinetics and pharmacodynamics of low doses of recombinant tissue plasminogen activator to establish a model for biosimilarity comparisons

Derhaschnig, U., Buchtele, N., Steiner, M. M., Drucker, C., Firbas, C., Schoergenhofer, C., Gelbenegger, G., König, F., Jilma, B., & Kovacevic, K. D. (2024) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2024.102518 · Cited by 1

Novel and emerging anesthetic drugs for the treatments of major depression: a comprehensive review of efficacy, mechanism, and outlook

Li, C., Wang, Z., Ye, X., Lv, J., Chen, F., Zhang, Y., Liu, J., Li, X., Duan, J., Wang, Y., et al. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1692751 · Cited by 2

Investigating the Multifaceted Nature of Radiation-Induced Coagulopathies in a Göttingen Minipig Model of Hematopoietic Acute Radiation Syndrome

Hritzo, B. A., Legesse, B., Ward, J. M., Kaur, A., Aghdam, S. Y., Kenchegowda, D., Holmes‐Hampton, G. P., & Moroni, M. (2021) · Radiation Research · doi:10.1667/rade-20-00073.1 · Cited by 1

Extending donor criteria: successful lung transplantation post ex vivo back table donor pulmonary artery thrombolysis

Jacob, S., Garg, P., Ahmed, M. M. E., & Makey, I. A. (2023) · Journal of Surgical Case Reports · doi:10.1093/jscr/rjad367 · Cited by 1

Diagnosis of Fibrinolytic Disorders

Chandler, W. L. (2012) · doi:10.1002/9781444398595.ch35 · Cited by 1

Is plasminogen deployed as a virulence factor by Northern Territory group A streptococcal isolates during invasive disease

McKay, F. C. (2005) · Research Online (University of Wollongong) · Cited by 1

Intrinsic Fibrinolysis and Arterial Thrombosis

Killewich, L. A. (2000) · Vascular Surgery · doi:10.1177/153857440003400302 · Cited by 1

Impairment of Endothelial Thromboprotective Function by Haemodynamic and Inflammatory Stress Implications for hypertensive disease

Ulfhammer, E. (2007) · Gothenburg University Publications Electronic Archive (Gothenburg University)

Key References: Basic Fibrinolysis and Thrombolysis Selected References: 1987–1997

Andreotti, F., Marco, E. D., & Patti, G. (2000) · Journal of Thrombosis and Thrombolysis · doi:10.1023/a:1018608614612

Changes of the Hemostatic Network in the Critically III

Boldt, J. (2001) · Springer eBooks · doi:10.1007/978-3-642-59467-0_12

Regional fluxes of tissue plasminogen activator in porcine endotoxemia

Nyberg, A. (2007) · Gothenburg University Publications Electronic Archive (Gothenburg University)

BLOOD PRESSURE ELEVATION: IMPACT ON CARDIOVASCULAR STRUCTURE AND ENDOGENOUS FIBRINOLYSIS

Ridderstråle, W. (2008) · Gothenburg University Publications Electronic Archive (Gothenburg University)

Alternative Mechanisms for Myocardial Ischemia in Syndrome X - New Diagnostic Markers

Crea, F., Buffon, A., Gaspardone, A., & Lanza, G. A. (1999) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-5181-2_11

Local tissue‐type plasminogen activator release in patients with ischemic stroke

Jood, K., Jern, C., Blomstrand, C., Jern, S., & Hrafnkelsdóttir, Þ. J. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02558.x

Regulation of vascular endothelial t-PA expression in inflammation: Potential target for pharmacological modulation

Larsson, P. (2011) · Gothenburg University Publications Electronic Archive (Gothenburg University)

Risk markers for a first myocardial infarction

Thøgersen, A. M. (2005) · KTH Publication Database DiVA (KTH Royal Institute of Technology)

in porcine endotoxemia

Nyberg, A. (2007)

Diabetes Mellitus and Cardiovascular Risk : epidemiology, etiology and intervention

Rautio, A. (2016) · KTH Publication Database DiVA (KTH Royal Institute of Technology)

Proprotein convertases and serine protease inhibitors : developing novel indirect-acting antiviral strategies against hepatitis c virus

Olmstead, A. D. (2013) · cIRcle (University of British Columbia) · doi:10.14288/1.0072449

Epigenetic regulation of gene expression in the vascular endothelium

Magnusson, M. (2016) · Gothenburg University Publications Electronic Archive (Gothenburg University)

Statement From the American Heart Association Mechanistic, Research, and Clinical Considerations for Youth : A Scientific Nontraditional Risk Factors and Biomarkers for Cardiovascular Disease:

Steinberger, J., Gidding, S. S., Hayman, L. L., McCrindle, B. W., de Ferranti, S. D., & Cook, S. L. (2011)

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Increased Clearance Explains Lower Plasma Levels of Tissue-Type Plasminogen Activator by Estradiol: Evidence for Potently Enhanced Mannose Receptor Expression in Mice

Lansink, M., Jong, M., Bijsterbosch, M. K., Bekkers, M., Toet, K. H., Havekes, L. M., EMEIS, J. J., & Kooistra, T. (2016)

Bilateral empyema secondary to Hemophilus influenzae epiglottitis

Kalininskiy, A., & Weis, J. M. (2021) · Respiratory Medicine Case Reports · doi:10.1016/j.rmcr.2021.101461

Normal Coagulation

Mann, K. G., & Brummel‐Ziedins, K. E. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5223-4.00033-0

Hyperfibrinolysis

Chandler, W. L. (2021) · Springer eBooks · doi:10.1007/978-3-030-56338-7_5

Tranexamic acid for cesarean delivery: induction of a regimen for postpartum hemorrhage?

Strauss, E. R., Vandyck, K. B., & Mazzeffi, M. A. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.08.030

The dynamics of thrombolysis over time in acute immunologic reactions

Kienbacher, C. L., Schoergenhofer, C., Ruzicka, G., Grafeneder, J., Hufnagl, C., Jilma, B., Schwameis, M., & Herkner, H. (2025) · Scientific Reports · doi:10.1038/s41598-024-84070-3

Additional file 1 of Association between coarse particulate matter and inflammatory and hemostatic markers in a cohort of midlife women

Davis, E., Malig, B. J., Broadwin, R., Ebisu, K., Basu, R., Gold, E. B., Qi, L., Derby, C. A., Park, S. K., & Wu, X. (. (2020) · Figshare · doi:10.6084/m9.figshare.13199089

Additional file 1 of Thrombus-specific/responsive biomimetic nanomedicine for spatiotemporal thrombolysis and alleviation of myocardial ischemia/reperfusion injury

Guo, X., Hong, T., Zang, J., Shao, R., Hou, X., Wang, K., Liu, W., Su, F., & He, B. (2023) · Figshare · doi:10.6084/m9.figshare.22602175

Ultrasound-Induced Cavitation of Immunoliposomes for Rapid Drug Release, Deep Thrombus Penetration, and Enhanced Thrombolysis

Zhang, L., Wang, S., Zhang, J., Li, P., Song, X., & Xu, S. (2026) · ACS Omega · doi:10.1021/acsomega.5c13385

Trafic neuronal de l’activateur tissulaire du plasminogène (tPA)

Lenoir, S. (2018) · theses.fr (ABES) · doi:10.70675/a417b9f7z899ez45afz9387z6cddae74df86

Les plexus choroïdes : une entrée au niveau cérébral pour l'activateur tissulaire du plasminogène (tPA)

Zuba, V. (2019) · doi:10.70675/6301de32z603dz4c40zbfbcze8e23a408331

Diagnostic utility of fibrinolytic markers as indicators of pediatric Plasmodium falciparum malaria: a case-control study in the Offinso-North District, GhanaPreprint

Gyedu, D., Twumasi, S., Addai‐Mensah, O., Boateng, L. A., Sackey, B., Abubakari, A. W., Kwarteng, S., Ayirebi, A. A., Dery, B. N., Odoka, B., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9418547/v1

Association of VTN Genotype with Plasminogen Activator Inhibitor-1 Activity in Late-Onset Alzheimer’s Disease

Ağırbaşlı, D., Ağırbaşlı, M. A., Cakir, M. E., & Müftüoğlu, M. (2026) · Genes · doi:10.3390/genes17050516

Multiobjective Engineering of Fibrin-Selective Thrombolytic Proteases with Enhanced Biocatalytic Efficiency and Inhibition Resistance

Toul, M., Slonková, V., Mičan, J., Thalerová, S., Pešková, M., Kittová, P., Scheer, P., Hložková, J., Brhelová, E., Ahmet Davut, A. K. S. U., et al. (2026) · ACS Catalysis · doi:10.1021/acscatal.6c02903

Acute Ischaemic Stroke: Therapeutic Targets and Key Modulators of the Fibrinolytic System and Clot Formation

Swarup, O., Balabanski, A. H., CLOUD, G. C., & Medcalf, R. L. (2026) · Translational Stroke Research · doi:10.1007/s12975-026-01502-0

Antibody-aptamer conjugate for shear-triggered tissue plasminogen activator release and thrombolysis

Ismail, E., Gong, F., Zhang, X. F., & Cheng, X. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.127587

Epigenetic influence on cardiovascular protective mechanisms in vivo: explorations of t-PA release and extracellular vesicle genetic content

Svennerholm, K. (2015)

Clearance of t-PA, PAI-1, and t-PA-PAI-1 complex in an isolated perfused rat liver system.

Wing, L. R., Gm, H., Bennett, B., & Booth, N. A. (1991) · PubMed · Cited by 39

Hepatic clearance of tissue plasminogen activator (t-PA) : the role of PAI-1

Wing, L. R. (1991)

Behaviour of tissue plasminogen activator, plasminogen activator inhibitor 1 and their complex in various disease states

Niwano, H., Takahashi, H., Tatewaki, W., Wada, K., Seki, Y., & Shibata, A. (1992) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199203040-00005 · Cited by 6

Effect of PAI-1 levels on the molar concentrations of active tissue plasminogen activator (t-PA) and t-PA/PAI-1 complex in plasma

Chandler, W. L., Trimble, S., Loo, S., & Mornin, D. (1990) · Blood · doi:10.1182/blood.v76.5.930.930 · Cited by 111

The role of plasminogen activator inhibitor type 1 in the clearance of tissue-type plasminogen activator by rat hepatoma cells.

Camani, C., Bachmann, F., & Kruithof, E. K. O. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37528-2 · Cited by 28